RDIF Chief says Sputnik V, Sputnik Light will neutralise Omicron MD Bureau30 Nov 2021 11:30 AM ISTNew Delhi: The Gamaleya Institute believes that both Sputnik V and Sputnik Light will neutralise the latest variant of Covid-19, Omicron, Kirill...
COVID infections in fully vaccinated rare, more severe in immunocompromised: Pfizer MD Bureau30 Nov 2021 11:00 AM ISTNew York: Covid-19 infections in the 'fully' vaccinated are rare but are more common and severe in people with weaker immune systems, according to a...
WHO releases update on Omicron Roshni Dhar29 Nov 2021 5:49 PM ISTOn 26 November 2021, WHO designated the variant B.1.1.529 a variant of concern, named Omicron. It is not yet clear whether Omicron is more...
Thermo Fisher confirms its COVID tests accurately detects Omicron variant Ruchika Sharma29 Nov 2021 4:39 PM ISTNew Delhi: Thermo Fisher Scientific Inc said on Monday its COVID-19 diagnostic tests can accurately detect the new coronavirus variant Omicron that...
Omicron triggers global alarm as WHO urges caution Roshni Dhar29 Nov 2021 4:00 PM ISTGlobal authorities reacted with alarm on Friday to a new coronavirus variant detected in South Africa, with the EU and Britain among those tightening...
Bharat Biotech resumes Covaxin exports Ruchika Sharma29 Nov 2021 2:59 PM ISTBengaluru: Indian vaccine maker Bharat Biotech said on Monday it has resumed export of its COVID-19 shot, Covaxin, and has executed long-pending...
CDSCO panel seeks additional data on Covovax from Serum Institute Ruchika Sharma29 Nov 2021 12:13 PM ISTNew Delhi: An expert panel of India's Central Drug Authority, which recently reviewed Serum Institute's application seeking emergency authorisation of...
USFDA issues clinical hold on Covaxin new drug application: Ocugen Ruchika Sharma29 Nov 2021 11:30 AM ISTMalvern: Ocugen, Inc. has recently announced that the U.S. Food and Drug Administration (FDA) has issued a clinical hold on the Company's...
Covid-19: Merck Molnupiravir significantly less effective in new analysis Ruchika Sharma29 Nov 2021 11:00 AM ISTNew Delhi: Merck & Co said on Friday updated data from its study of its experimental COVID-19 pill showed the drug was significantly less...
Reformulated vaccine for Omicron may be ready by early 2022: Moderna Ruchika Sharma29 Nov 2021 10:00 AM ISTNew Delhi: Moderna Inc. Chief Medical Officer Paul Burton said he suspects the new omicron coronavirus variant may elude current vaccines, and if so,...
Decline in Covaxin effectiveness to 50 percent during Delta-driven COVID surge not bad: Experts Medical Dialogues Bureau28 Nov 2021 11:00 AM ISTNew Delhi: The decline in the effectiveness of Covaxin, India's indigenous COVID-19 vaccine, from 77.8% to 50% during a Delta-driven case surge in...
Covid-19: Pfizer-BioNTech, Moderna expect data on shot protection against new variant soon Ruchika Sharma28 Nov 2021 10:30 AM ISTFrankfurt: BioNTech SE said on Friday it expects more data on a worrying new coronavirus variant detected in South Africa within two weeks to...
